| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0009 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 0.001 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 0.002 |